查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1881572

藥物動力學服務市場－全球產業規模、佔有率、趨勢、機會和預測，按藥物類型、應用、最終用途、地區和競爭格局分類，2020-2030年預測

Pharmacokinetics Services Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drug Type, By Application, By End-use, by region, and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 182 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024年全球藥物動力學服務市場規模為10.7436億美元，預計2030年將以8.2%的複合年成長率成長至17.2391億美元。藥物動力學（PK）服務涵蓋對藥物在生物系統中的吸收、分佈、代謝和排泄（ADME）的科學分析，在最佳化治療劑量、提高藥物療效以及確保臨床前和臨床開發過程中的合規性方面發揮關鍵作用。推動這項關鍵服務市場成長的主要因素包括：全球醫藥研發投入的不斷增加、包括生物製劑在內的新型藥物實體日益複雜化以及對個人化醫療策略的日益重視。

市場概覽
預測期 2026-2030
2024年市場規模 10.7436億美元
2030年市場規模 17.2391億美元
2025-2030年複合年成長率 8.2%
成長最快的細分市場 生物技術和製藥公司
最大的市場 北美洲

主要市場促進因素

主要市場挑戰

主要市場趨勢

目錄

第1章：產品概述

第2章：研究方法

第3章：執行概要

第4章：客戶之聲

第5章：全球藥物動力學服務市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依藥物類型（小分子、大分子）
    • 依申請方式（中小企業、大型企業）
    • 按最終用途分類（生物技術和製藥公司、學術和政府研究機構、其他）
    • 按地區
    • 按公司（2024 年）
  • 市場地圖

第6章：北美藥物動力學服務市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲藥物動力學服務市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區藥物動力學服務市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲藥物動力學服務市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲藥物動力學服務市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章：市場動態

  • 促進要素
  • 挑戰

第12章：市場趨勢與發展

  • 併購（如有）
  • 產品發布（如有）
  • 最新進展

第13章：全球藥物動力學服務市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商議價能力
  • 顧客的力量
  • 替代產品的威脅

第15章：競爭格局

  • Evotec AG
  • Certara, LP
  • Pacific BioLabs
  • GVK Biosciences Private Limited
  • Shanghai Medicilon Inc.
  • Pharmaceutical Product Development, LLC
  • Charles River Laboratories International, Inc.
  • PAREXEL International Corporation
  • Eurofins Scientific SE
  • Frontage Labs

第16章：策略建議

第17章調查會社について,免責事項

簡介目錄
Product Code: 21117

The Global Pharmacokinetics Services Market, valued at USD 1074.36 Million in 2024, is projected to experience a CAGR of 8.2% to reach USD 1723.91 Million by 2030. Pharmacokinetics (PK) services encompass the scientific analysis of drug absorption, distribution, metabolism, and excretion (ADME) within biological systems, playing a pivotal role in optimizing therapeutic dosages, enhancing drug efficacy, and ensuring regulatory compliance throughout preclinical and clinical development. The market for these essential services is primarily propelled by increasing global pharmaceutical research and development investments, the rising complexity of novel drug entities including biologics, and the expanding focus on personalized medicine strategies.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 1074.36 Million
Market Size 2030USD 1723.91 Million
CAGR 2025-20308.2%
Fastest Growing SegmentBiotechnology and Pharmaceutical Companies
Largest MarketNorth America

Key Market Drivers

The global pharmacokinetics services market is significantly driven by the rising complexity of drug development and the increasing demand for biopharmaceuticals. Modern drug development increasingly targets intricate novel entities, especially for rare diseases and personalized medicine, which necessitates highly specialized pharmacokinetic analysis. This heightened complexity demands sophisticated study designs and advanced analytical techniques to understand drug behavior in diverse patient populations. According to a research article in the British Journal of Pharmacology, in March 2024, "Novel drugs approved by the EMA, the FDA, and the MHRA in 2023: A year in review," over half of the seventy novel drugs authorized in 2023 targeted rare diseases or intractable forms of cancer, underscoring this industry shift towards challenging therapeutic areas.

Key Market Challenges

The substantial costs and inherent complexities associated with conducting advanced pharmacokinetic (PK) studies present a significant impediment to the growth of the Global Pharmacokinetics Services Market. The specialized equipment, highly skilled personnel, and extensive validation required for these studies, particularly for complex biologics and personalized therapies, translate into considerable financial outlays. This financial burden can restrict the number of drug candidates that companies, especially smaller biotechnology firms, can advance into development, thereby limiting the overall demand for PK services.

Key Market Trends

The integration of Artificial Intelligence and Machine Learning into pharmacokinetic modeling represents a pivotal trend reshaping drug development by enhancing efficiency and predictive accuracy. These advanced computational methods enable the processing of extensive datasets, improving the prediction of drug absorption, distribution, metabolism, and excretion (ADME) properties with greater precision than traditional approaches. According to a December 2023 survey by Rackspace Technology and Dell/VMware, 68% of pharmaceutical businesses identified pervasive AI as having the highest potential impact on their business, indicating a strong industry recognition of this technology's transformative power. This integration allows for more informed decision-making earlier in the development pipeline, potentially reducing the need for costly in vivo experiments and accelerating the identification of promising drug candidates.

Key Market Players

  • Evotec AG
  • Certara, L.P.
  • Pacific BioLabs
  • GVK Biosciences Private Limited
  • Shanghai Medicilon Inc.
  • Pharmaceutical Product Development, LLC
  • Charles River Laboratories International, Inc.
  • PAREXEL International Corporation
  • Eurofins Scientific SE
  • Frontage Labs

Report Scope:

In this report, the Global Pharmacokinetics Services Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Pharmacokinetics Services Market, By Drug Type:

  • Small Molecules
  • Large Molecules

Pharmacokinetics Services Market, By Application:

  • Small and Medium Enterprise
  • Large Enterprise

Pharmacokinetics Services Market, By End-Use:

  • Biotechnology & Pharmaceutical Companies
  • Academic & Government Research Institutes
  • Others

Pharmacokinetics Services Market, By Region:

  • North America
  • Europe
  • Asia Pacific
  • South America
  • MEA

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Pharmacokinetics Services Market.

Available Customizations:

Global Pharmacokinetics Services Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Pharmacokinetics Services Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Drug Type (Small Molecules, Large Molecules)
    • 5.2.2. By Application (Small and Medium Enterprise, Large Enterprise)
    • 5.2.3. By End-Use (Biotechnology & Pharmaceutical Companies, Academic & Government Research Institutes, others)
    • 5.2.4. By Region
    • 5.2.5. By Company (2024)
  • 5.3. Market Map

6. North America Pharmacokinetics Services Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Drug Type
    • 6.2.2. By Application
    • 6.2.3. By End-Use
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Pharmacokinetics Services Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Drug Type
        • 6.3.1.2.2. By Application
        • 6.3.1.2.3. By End-Use
    • 6.3.2. Canada Pharmacokinetics Services Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Drug Type
        • 6.3.2.2.2. By Application
        • 6.3.2.2.3. By End-Use
    • 6.3.3. Mexico Pharmacokinetics Services Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Drug Type
        • 6.3.3.2.2. By Application
        • 6.3.3.2.3. By End-Use

7. Europe Pharmacokinetics Services Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Drug Type
    • 7.2.2. By Application
    • 7.2.3. By End-Use
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Pharmacokinetics Services Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Drug Type
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By End-Use
    • 7.3.2. France Pharmacokinetics Services Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Drug Type
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By End-Use
    • 7.3.3. United Kingdom Pharmacokinetics Services Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Drug Type
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By End-Use
    • 7.3.4. Italy Pharmacokinetics Services Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Drug Type
        • 7.3.4.2.2. By Application
        • 7.3.4.2.3. By End-Use
    • 7.3.5. Spain Pharmacokinetics Services Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Drug Type
        • 7.3.5.2.2. By Application
        • 7.3.5.2.3. By End-Use

8. Asia Pacific Pharmacokinetics Services Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Drug Type
    • 8.2.2. By Application
    • 8.2.3. By End-Use
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Pharmacokinetics Services Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Drug Type
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By End-Use
    • 8.3.2. India Pharmacokinetics Services Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Drug Type
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By End-Use
    • 8.3.3. Japan Pharmacokinetics Services Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Drug Type
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By End-Use
    • 8.3.4. South Korea Pharmacokinetics Services Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Drug Type
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By End-Use
    • 8.3.5. Australia Pharmacokinetics Services Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Drug Type
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By End-Use

9. Middle East & Africa Pharmacokinetics Services Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Drug Type
    • 9.2.2. By Application
    • 9.2.3. By End-Use
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Pharmacokinetics Services Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Drug Type
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By End-Use
    • 9.3.2. UAE Pharmacokinetics Services Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Drug Type
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By End-Use
    • 9.3.3. South Africa Pharmacokinetics Services Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Drug Type
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By End-Use

10. South America Pharmacokinetics Services Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Drug Type
    • 10.2.2. By Application
    • 10.2.3. By End-Use
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Pharmacokinetics Services Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Drug Type
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By End-Use
    • 10.3.2. Colombia Pharmacokinetics Services Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Drug Type
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By End-Use
    • 10.3.3. Argentina Pharmacokinetics Services Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Drug Type
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By End-Use

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Pharmacokinetics Services Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Evotec AG
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Certara, L.P.
  • 15.3. Pacific BioLabs
  • 15.4. GVK Biosciences Private Limited
  • 15.5. Shanghai Medicilon Inc.
  • 15.6. Pharmaceutical Product Development, LLC
  • 15.7. Charles River Laboratories International, Inc.
  • 15.8. PAREXEL International Corporation
  • 15.9. Eurofins Scientific SE
  • 15.10. Frontage Labs

16. Strategic Recommendations

17. About Us & Disclaimer